Advancing our commitment to our peer reviewers

Rashmi B. Halker Singh; Sarah M. Bobker; Jason L. Roberts; Larry Charleston; Matthew S. Robbins; Amynah Pradhan; Till Sprenger; Patricia Pozo-Rosich; Serena L. Orr; Scott W. Powers; Timothy T. Houle; Dana P. Turner; Amy A. Gelfand

doi:10.1111/head.14211

Advancing our commitment to our peer reviewers

Rashmi B. Halker Singh, Sarah M. Bobker, Jason L. Roberts, Larry Charleston, Matthew S. Robbins, Amynah Pradhan, Till Sprenger, Patricia Pozo-Rosich, Serena L. Orr, Scott W. Powers, Timothy T. Houle, Dana P. Turner, Amy A. Gelfand

Neurology

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1299-1301
Number of pages	3
Journal	Headache
Volume	61
Issue number	9
DOIs	https://doi.org/10.1111/head.14211
State	Published - Oct 2021

Keywords

academic culture
academic medicine
ethics
peer review
volunteerism

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1111/head.14211

Cite this

@article{ea4e51eef5c14a9fb28df9317614fb4f,

title = "Advancing our commitment to our peer reviewers",

keywords = "academic culture, academic medicine, ethics, peer review, volunteerism",

author = "{Halker Singh}, {Rashmi B.} and Bobker, {Sarah M.} and Roberts, {Jason L.} and Larry Charleston and Robbins, {Matthew S.} and Amynah Pradhan and Till Sprenger and Patricia Pozo-Rosich and Orr, {Serena L.} and Powers, {Scott W.} and Houle, {Timothy T.} and Turner, {Dana P.} and Gelfand, {Amy A.}",

note = "Funding Information: RHS: Dr. Halker Singh receives payment from the American Headache Society for her role as Online and Social Media Editor of . She is a section editor for . She received grant support from Amgen. In the last 12 months, she had been a scientific consultant for Impel and Teva. SMB: Dr. Bobker has no financial interests or relationships to disclose. JLR: Dr. Roberts receives a stipend from the American Headache Society for his work as the Executive Editor of . LC: Dr. Charleston has received personal compensation for serving as a consultant for Allergan/AbbVie, Alder/Lundbeck, and Biohaven; is on the advisory panel for Ctrl M Health (stock); received grant support from the Disparities in Headache Advisory Council; served as an Expert Witness for Vaccine Injury Compensation Program. He is a non‐compensated associate editor for and serves as a non‐compensated Board Member‐at‐Large for the Alliance for Headache Disorders Advocacy. MSR: Dr. Robbins serves in non‐remunerative positions on the Board of Directors for the American Headache Society and the New York State Neurological Society. He is an associate editor for and a section editor for . He receives book royalties from Wiley. AP: Dr. Pradhan holds grant support from Lundbeck. TS: Dr. Sprenger has received no personal compensation. The employer of Till Sprenger has in the past 5 years received compensation for consulting or speaking from Biogen Idec, Eli Lilly, Actelion, Desitin, Electrocore, Janssen, Merck Serono, Mitsubishi Pharma, Novartis, Roche, Sandoz, Teva, and Sanofi Genzyme. PPR: In the last 5 years, Dr. Pozo‐Rosich declares that her research group has received grants from AGAUR; EraNet NEURON: La Caixa Foundation: Instituto Investigaci{\'o}n Carlos III; Migraine Research Foundation; MINECO; Mutual Medica; PERIS, and Novartis. She has received honoraria as a consultant and participated in advisory boards for Allergan, Amgen, Almirall, Biohaven, Chiesi, Eli Lilly, Novartis, and Teva Pharmaceuticals. She has collaborated in Medical Education projects together with Allergan, Almirall, Chiesi, Eli Lilly, Medlink, Medscape, Neurodiem, Novartis, and Teva Pharmaceuticals. SLO: Serena L. Orr receives royalties for book publication from Cambridge University Press, is an Associate Editor for , and holds research funding from the Canadian Institutes of Health Research and the Alberta Children{\textquoteright}s Hospital Research Institute. SWP: Dr. Powers receives research and training grant funding paid to his institution from the National Institutes of Health (NINDS, NCCIH, NINR, NCATS, NIDDK, NICHD), National Headache Foundation, Migraine Research Foundation, and Cystic Fibrosis Foundation. He has been a scientific consultant for Theranica and Biohaven in the past 12 months. TTH: Dr. Houle serves as a paid Statistical Editor for the journals and . He is an editorial board member of . In the past several years, he has received research/statistical consulting fees from Eli Lilly and GlaxoSmithKline. He receives research funding from the National Institutes of Health. DPT: Dr. Turner receives a stipend from the American Headache Society for her role as Design and Methods Advisor of . She receives research funding from the National Institutes of Health. AAG: In the last 12 months, Dr. Gelfand has received honoraria from UpToDate (for authorship). She receives payment from the American Headache Society for her role as Editor of . She received grant support from the Duke Clinical Research Institute and the UCSF Resource Allocation Program. Her spouse reports research support (to UCSF) from Genentech for a clinical trial, honoraria for editorial work for Dynamed plus, and personal compensation for medical‐legal consulting. Headache Neurology and Neuroscience Reports Headache Headache Headache Current Pain and Headache Reports Headache Anesthesiology Headache Cephalalgia Headache Headache",

year = "2021",

month = oct,

doi = "10.1111/head.14211",

language = "English (US)",

volume = "61",

pages = "1299--1301",

journal = "Headache",

issn = "0017-8748",

publisher = "Wiley-Blackwell",

number = "9",

}

TY - JOUR

T1 - Advancing our commitment to our peer reviewers

AU - Halker Singh, Rashmi B.

AU - Bobker, Sarah M.

AU - Roberts, Jason L.

AU - Charleston, Larry

AU - Robbins, Matthew S.

AU - Pradhan, Amynah

AU - Sprenger, Till

AU - Pozo-Rosich, Patricia

AU - Orr, Serena L.

AU - Powers, Scott W.

AU - Houle, Timothy T.

AU - Turner, Dana P.

AU - Gelfand, Amy A.

N1 - Funding Information: RHS: Dr. Halker Singh receives payment from the American Headache Society for her role as Online and Social Media Editor of . She is a section editor for . She received grant support from Amgen. In the last 12 months, she had been a scientific consultant for Impel and Teva. SMB: Dr. Bobker has no financial interests or relationships to disclose. JLR: Dr. Roberts receives a stipend from the American Headache Society for his work as the Executive Editor of . LC: Dr. Charleston has received personal compensation for serving as a consultant for Allergan/AbbVie, Alder/Lundbeck, and Biohaven; is on the advisory panel for Ctrl M Health (stock); received grant support from the Disparities in Headache Advisory Council; served as an Expert Witness for Vaccine Injury Compensation Program. He is a non‐compensated associate editor for and serves as a non‐compensated Board Member‐at‐Large for the Alliance for Headache Disorders Advocacy. MSR: Dr. Robbins serves in non‐remunerative positions on the Board of Directors for the American Headache Society and the New York State Neurological Society. He is an associate editor for and a section editor for . He receives book royalties from Wiley. AP: Dr. Pradhan holds grant support from Lundbeck. TS: Dr. Sprenger has received no personal compensation. The employer of Till Sprenger has in the past 5 years received compensation for consulting or speaking from Biogen Idec, Eli Lilly, Actelion, Desitin, Electrocore, Janssen, Merck Serono, Mitsubishi Pharma, Novartis, Roche, Sandoz, Teva, and Sanofi Genzyme. PPR: In the last 5 years, Dr. Pozo‐Rosich declares that her research group has received grants from AGAUR; EraNet NEURON: La Caixa Foundation: Instituto Investigación Carlos III; Migraine Research Foundation; MINECO; Mutual Medica; PERIS, and Novartis. She has received honoraria as a consultant and participated in advisory boards for Allergan, Amgen, Almirall, Biohaven, Chiesi, Eli Lilly, Novartis, and Teva Pharmaceuticals. She has collaborated in Medical Education projects together with Allergan, Almirall, Chiesi, Eli Lilly, Medlink, Medscape, Neurodiem, Novartis, and Teva Pharmaceuticals. SLO: Serena L. Orr receives royalties for book publication from Cambridge University Press, is an Associate Editor for , and holds research funding from the Canadian Institutes of Health Research and the Alberta Children’s Hospital Research Institute. SWP: Dr. Powers receives research and training grant funding paid to his institution from the National Institutes of Health (NINDS, NCCIH, NINR, NCATS, NIDDK, NICHD), National Headache Foundation, Migraine Research Foundation, and Cystic Fibrosis Foundation. He has been a scientific consultant for Theranica and Biohaven in the past 12 months. TTH: Dr. Houle serves as a paid Statistical Editor for the journals and . He is an editorial board member of . In the past several years, he has received research/statistical consulting fees from Eli Lilly and GlaxoSmithKline. He receives research funding from the National Institutes of Health. DPT: Dr. Turner receives a stipend from the American Headache Society for her role as Design and Methods Advisor of . She receives research funding from the National Institutes of Health. AAG: In the last 12 months, Dr. Gelfand has received honoraria from UpToDate (for authorship). She receives payment from the American Headache Society for her role as Editor of . She received grant support from the Duke Clinical Research Institute and the UCSF Resource Allocation Program. Her spouse reports research support (to UCSF) from Genentech for a clinical trial, honoraria for editorial work for Dynamed plus, and personal compensation for medical‐legal consulting. Headache Neurology and Neuroscience Reports Headache Headache Headache Current Pain and Headache Reports Headache Anesthesiology Headache Cephalalgia Headache Headache

PY - 2021/10

Y1 - 2021/10

KW - academic culture

KW - academic medicine

KW - ethics

KW - peer review

KW - volunteerism

UR - http://www.scopus.com/inward/record.url?scp=85116925674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85116925674&partnerID=8YFLogxK

U2 - 10.1111/head.14211

DO - 10.1111/head.14211

M3 - Editorial

C2 - 34643953

AN - SCOPUS:85116925674

SN - 0017-8748

VL - 61

SP - 1299

EP - 1301

JO - Headache

JF - Headache

IS - 9

ER -

Advancing our commitment to our peer reviewers

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this